Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,122
Closed -$156K 322
2021
Q4
$156K Buy
2,122
+338
+19% +$22.8K 0.02% 353
2021
Q3
$123K Buy
1,784
+31
+2% +$2.36K 0.01% 374
2021
Q2
$147K Buy
1,753
+30
+2% +$2.5K 0.02% 359
2021
Q1
$140K Sell
1,723
-148
-8% -$12.6K 0.01% 396
2020
Q4
$163K Buy
1,871
+103
+6% +$8.91K 0.02% 377
2020
Q3
$159K Buy
1,768
+45
+3% +$4.34K 0.02% 381
2020
Q2
$179K Sell
1,723
-24,142
-93% -$2.33M 0.02% 447
2020
Q1
$1.89M Buy
25,865
+65
+0.3% +$4.91K 0.28% 97
2019
Q4
$2.25M Sell
25,800
-5,812
-18% -$497K 0.19% 115
2019
Q3
$2.35M Sell
31,612
-14,121
-31% -$1.14M 0.22% 113
2019
Q2
$3.88M Buy
45,733
+24,729
+118% +$1.98M 0.27% 81
2019
Q1
$1.81M Buy
+21,004
New +$1.71M 0.14% 159

Other funds holding INCY

First Quadrant's INCY Position: Q1 2022 in Review

First Quadrant sold out of Incyte (INCY) in Q1 2022, closing a stake of 2,122 shares — an estimated $156K sold.

First Quadrant first reported a position in INCY in Q1 2019 and held it in 12 quarters. The position peaked at $3.88M in Q2 2019. 531 funds tracked by Wall St. Rank hold INCY as of Q1 2022.

  • First Quadrant reported no remaining Incyte position as of Q1 2022 after selling out during the quarter.
  • First Quadrant sold 2,122 Incyte shares in Q1 2022, an estimated $156K.
  • First Quadrant first reported a position in Incyte in Q1 2019 and held it in 12 quarters.
  • First Quadrant's Incyte position peaked at $3.88M in Q2 2019.
  • 531 funds tracked by Wall St. Rank held Incyte as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.